-
5m 3sPart 2 | Session 2 Cordella PA Sensor System in NYHA Class III HF Patients: PROACTIVE-HF
-
7m 19s
-
5m 24sPart 2 | Session 4 Timing of Cardio-Kidney Protection with SGLT2i
-
2m 54s
-
4m 40sPart 2 | Session 7 FINE-HEART: Design & Baseline Characteristics
-
11m 58sPart 2 | Session 8 HFA 24: The RELIEVE-HF Trial: Differential Effects of V-Wave Device
-
15m 26sPart 1 | Session 1 HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie
-
10m 15sPart 1 | Session 2 Late-Breaker Discussion: The TITRATE-HF Study
-
12m 4sPart 1 | Session 3 Late-Breaker Discussion: Insights from the STEP-HFpEF
-
8m 37sPart 1 | Session 4 Late-Breaker Discussion: Findings from PACT-HF
Investigator, Prof Nicolas Girerd (University Hospital of Nancy, FR) joins us to discuss the findings from the TELESAT study (NCT06312501).
This multicenter observational longitudinal cohort study investigated whether a Remote Patient Monitoring (RPM) program (Satelia®Cardio, Satelia) is able to prevent cardiac decompensation by detecting weak signals of decompensation early in patients with chronic heart failure in France. The study enrolled 20,000 participants with heart failure, with the primary outcome being all-cause death from August 2018 to December 2021.
Findings showed an association between RPM programmes and lower all-cause mortality (35% reduction) based on weight and symptoms evaluation coupled with tele-education.
Interview Questions:
- What was the reasoning behind this trial?
- What was the patient population and study design?
- What were the key results revealed at HFA 24?
- How should these findings impact practice and future research?
- What surprised you about the results of TELESAT study?
Recorded on-site at HFA 2024, Lisbon.
Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Association’s annual congress, Heart Failure 2024.
Dive deep into novel data with in-depth and critical discussions led by Late-breaker host Dr Harriette Van Spall and her expert guests.
For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators.
Comments